- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Aegerion Pharmaceuticals Inc+ Add to Watchlist
AEGR:US60.0900 USD 0.8700 1.43%
As of 20:10:00 ET on 05/24/2013.
Company Profile for Aegerion Pharmaceuticals Inc (AEGR)
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic desease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.
Aegerion Pharmaceuticals Inc
Key Executives for Aegerion Pharmaceuticals Inc (AEGR)
|Marc C BeerChief Executive Officer||Mark J FitzpatrickChief Financial Officer|
|Mark SumerayChief Medical Officer||Martha J CarterChief Regulatory Officer|
|Craig FraserPresident: US Commercial||Anne Marie CookSenior VP/Secretary/Gen Cnsl|